This is a $1,239.95 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company. The order is for the company's APLIGRAF product, which is a wound dressing and tissue regeneration solution. Organogenesis has been awarded numerous prime federal contracts by the DLA and Department of Veterans Affairs (VA) to provide advanced wound care and surgical products. This specific award is not associated with a set-aside program....
This is a delivery order awarded by the Medical Supply Chain of the Defense Logistics Agency (DLA) to Organogenesis Inc., a leading regenerative medicine company. The order is for $1,239.95 in APLIGRAF wound care products, with a completion date of March 29, 2024. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery Contract (IDC) that Organogenesis holds with the DLA for wound care dressings, discs, and other medical materials. Organogenesis has also...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medical products. The contract is a delivery order for the advanced wound care product APLIGRAF. Organogenesis has multiple Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, including a $25 million single-award IDC with the VA for surgical implants, a $30 million Federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The $1,239.95 fixed-price delivery order is for the supply of the APLIGRAF wound care product. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, valued at up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The $1,239.95 fixed-price order is for the advanced wound care product APLIGRAF. This delivery order is part of a larger $49.5 million Indefinite Delivery Contract (IDC) the DLA has with Organogenesis for a variety of wound care dressings and medical supplies, which runs from June 2021 to June 2026. Organogenesis also...
This is a $1,239.95 fixed-price delivery order awarded to Organogenesis Inc., a leading regenerative medicine company, by the Defense Logistics Agency Troop Support Medical (DLA Troop Support). The award is for APLIGRAF, a wound care product provided under contract SPE2DE21D0005|SPE2D624F1W56 with a completion date of March 21, 2024. Organogenesis Inc. has been awarded numerous prime federal contracts to provide wound care dressings, surgical implants, tissue regeneration products, and other...
This $1,239.95 fixed-price delivery order was awarded to Organogenesis Inc., a regenerative medicine company, by the Medical Supply Chain division of the Defense Logistics Agency. The order is for APLIGRAF, a wound care product, and has a completion date of March 20, 2024. Organogenesis previously held several large Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs and Defense Logistics Agency to supply surgical implants, wound care matrices, and other tissue...
This contract award to Organogenesis Inc., a leading regenerative medicine company, is for the delivery of APLIGRAF medical products. The $1,239.95 fixed-price delivery order falls under a larger $49.5 million multiple-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, a Defense agency, for wound care dressings, discs, and other medical materials. Organogenesis has also secured additional federal contracts with the Department of Veterans Affairs...
This is a federal contract award from the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The award, valued at $1,239.95, is for the delivery of APLIGRAF, a skin substitute product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) vehicle held by Organogenesis with the DLA, valued at $49.5 million, for wound care dressings and medical supplies. This IDC was awarded as a total small...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company, for the supply of APLIGRAF wound dressings. The award, valued at $2,479.90, has a fixed-price with economic price adjustment pricing type and an ultimate completion date of April 8, 2024. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery Contract (IDC) awarded by DLA to Organogenesis for wound care...